You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 8, August 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Predominance of Oligoclonal IgG Type {lambda} in CSF in Aseptic Meningitis-Reply

Aril Fryden, MD
Department of Infectious Diseases

Hans Link, MD
Department of Neurology University Hospital S-581 85 Linköping, Sweden

Arch Neurol. 1980;37(8):530.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Dr Bollengier's statements are incorrect. The IgG predominance in the CSF from patients with aseptic meningitis was described in 19711; seven of 39 patients with a variety of infectious disorders of the nervous system presented in that report (Table 9) had a k /{lambda} ratio in CSF of 0.5 or less, whereas none of these patients had an abnormally high ratio (>1.7), in contrast to the situation in multiple sclerosis (MS), where 33 of 64 patients had ratios higher than 1.7. The occurrence of free light chains in the CSF from inter alia patients with MS was described already in 1967.2

The report by Dr Bollengier and his group from 1975 was not included among our references because it dealt with MS and subacute sclerosing panencephalitis, whereas the purpose of our article was to introduce immunofixation after agarose gel electrophoresis for the characterization of oligoclonal immunoglobulins with . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.